Firms

TCD Capital

TCD Capital

TCD Capital is a Brussels-based venture capital and private equity manager investing in European growth companies across Technology, Life Sciences and Smart Living. Its legal manager is active Belgian company TheClubDeal Capital Advisors SA, enterprise BE0647.570.713, incorporated January 28, 2016. The firm announced its change of public brand from TheClubDeal to TCD Capital on February 19, 2024; this does not change the legal manager. Its own portfolio includes brain clinical-trial analytics, neurostimulation, blood-brain-barrier therapeutics, surgical planning and AI-enabled restaurant supply management. Fund I and Fund II are separate investment vehicles; the manager also arranges club deals and advisory mandates. Fund II completed its final close at approximately EUR40 million at the end of June 2023. Separate co-investments, company financing rounds and aggregate structured transactions are not added to fund capital. Current public affiliations distinguish executive staff, non-executive partners, specialist advisers and Fund II board members. Two named interns have initials rather than genuine public headshots. Institutional investment attribution is preserved separately from individual club-deal investors, with no guessed fund allocation or personal check.

Founded
—
Type
Venture capital

Funds2

  • TCD Capital I—

    First fund, current own portfolio labels vintage2016. The dated rebrand announcement calls the vehicle TCD CAPITAL I; earlier manager materials call it ClubI. Exact registered fund enterprise number, final committed size and full closing day are not established. Aggregate structured club deals are not substituted for this fund size.

  • TCD Capital II€40M

    Second vehicle, Belgian PRICAF/PRIVAK identified in dated own rebrand announcement; current portfolio labels vintage2021. Original manager July10,2023 article confirms final hard close at end of June2023 around EUR40 million in commitments. Amount is expressly approximate and no full closing day is invented. Around EUR13M deployed and additional EUR10M co-investment are separate, not added to fund size. LP commitments are not represented as fully paid cash calls.

Team

Operations and support

Christophe FlorinChristophe FlorinFund II Board Member
Colette PlasmanColette PlasmanFund II Board Member
Evrard de JongheEvrard de JongheInvestment Associate
Geoffroy BoonenGeoffroy BoonenChairman of the General Partner
Hubert BonnetHubert BonnetNon-Executive Partner
Iago Colera BorrasInvestment Analyst Intern
Jean-Louis DubruleJean-Louis DubruleNon-Executive Partner
Jean-Louis Van HouweJean-Louis Van HouweTech Advisor, Non-Executive Partner
Jean-Marc HeynderickxJean-Marc HeynderickxNon-Executive Partner
Jean-Marc LegrandJean-Marc LegrandFounding and Managing Partner
Louis de ThanhofferLouis de ThanhofferLife Sciences Advisor
Léri CalvarInvestment Analyst Intern
Marc SpeeckaertMarc SpeeckaertChairman of the Fund II Board
Nicolas RobertiNicolas RobertiNon-Executive Partner
Stéphane VerbeeckStéphane VerbeeckSmart Living Advisor, Non-Executive Partner

Co-investing

Investments